# Launch Your Healthcare Career with the Revassian Sales Development Program
Entering the medical device sector offers a unique chance to combine business acumen with life-saving healthcare solutions. If you are a driven graduate looking to make a meaningful impact, the Revassian Sales Development Program (RSDP) Batch 1 2025 by PT. Revass Utama Medika provides the ideal gateway.
PT. Revass Utama Medika stands as a premier distributor and marketer of interventional cardiology medical devices in Indonesia. Originating as an importer of top-tier stents and balloons from OrbusNeich Medical in the Netherlands, the company has grown exponentially. Today, PT. Revass operates a robust sales network spanning 30 major cities nationwide, driven by an unwavering commitment to delivering superior cardiovascular solutions and building trusted partnerships across the Indonesian healthcare ecosystem.
## What is the Revassian Sales Development Program (RSDP)?
The RSDP is an intensive, 12-month Management Trainee initiative specifically engineered to cultivate top-tier talent. This program focuses on accelerating business expansion and driving sales excellence by mentoring ambitious individuals.
Participating in this structured career path prepares you to step into pivotal leadership roles within the medical technology sector, including:
* Senior Medical Device Executive
* Professional Medical Device Executive
* District Sales Manager
Throughout the 12-month journey, trainees spearhead regional sales operations, shoulder accountability for revenue and profitability milestones, and shape the future of medical distribution in Indonesia.
## Core Responsibilities of an RSDP Trainee
As a management trainee in this program, your daily activities combine strategic planning, client engagement, and operational execution. The core duties encompass:
1. Revenue Generation & Target Achievement: Consistently hit or exceed company-mandated sales goals while proactively spotting emerging market opportunities and prospective clients.
2. Client Relationship Management: Foster long-term, professional bonds with healthcare providers and deliver prompt, effective solutions to client inquiries.
3. Product Demonstrations & Presentations: Articulate the clinical advantages and technical features of advanced cardiology devices to medical professionals through engaging pitches and live demos.
4. Negotiation & Contract Closure: Navigate pricing discussions, finalize terms and conditions, and secure successful agreements.
5. Market Intelligence & Strategy: Track competitor movements, analyze healthcare sector trends, and relay critical client feedback directly to upper management and product teams.
6. Sales Administration & Collaboration: Maintain precise digital records in company databases, manage documentation, and partner cross-functionally to drive organizational success.
## Candidate Qualifications and Requirements
PT. Revass Utama Medika seeks highly motivated, energetic professionals who possess the drive to excel in a competitive marketplace. To qualify for RSDP Batch 1 2025, applicants must meet the following criteria:
* Educational Background: Hold a Bachelor’s Degree (S1) from any academic major.
* Academic Excellence: Maintain a minimum Grade Point Average (GPA) of 3.00 on a 4.00 scale.
* Experience Level: Open to both ambitious fresh graduates and professionals with less than two years of working experience.
* Age Restriction: Between 21 and 25 years of age.
* Mobility: Demonstrate complete willingness and flexibility to be stationed in various sales posts across Indonesia.
## Why Join PT. Revass Utama Medika?
Building a career with PT. Revass means aligning with a market leader dedicated to continuous professional development. Trainees receive extensive mentorship, hands-on industry training, and clear pathways to leadership. By bridging cutting-edge medical technology with clinical needs, you play a vital role in elevating patient care standards across the archipelago.
Take the next decisive step in your professional journey. Bring your ambition, drive commercial success, and redefine healthcare distribution standards in Indonesia by applying for the RSDP Batch 1 2025 today.